Can I Take Glutathione with Accutane (Isotretinoin)?

Why This Combination Raises Questions

Isotretinoin is highly effective for severe acne, but it requires liver monitoring throughout treatment because transaminase elevations are a recognized, if usually mild and self-limited, side effect. That reality is what leads people already taking or considering glutathione, whether for skin, general antioxidant support, or "liver detox" marketing, to ask whether it helps, hurts, or simply does nothing when combined with isotretinoin.

The Liver Connection

Isotretinoin undergoes extensive hepatic metabolism, and its prescribing information describes high plasma protein binding (approximately 99.9%, primarily to albumin) [16]. Elevated liver transaminases are a known, generally reversible finding during isotretinoin therapy; retrospective cohort data on isotretinoin lab monitoring have reported transaminase elevations in a meaningful minority of patients, most of them mild and not requiring the drug to be stopped. Exact percentages differ across studies and definitions of "elevated," so treat any specific figure, including the ranges cited here, as a starting point to confirm with your prescriber rather than a fixed number.

Glutathione, a tripeptide of glutamate, cysteine, and glycine, is the principal intracellular antioxidant in hepatocytes and supports Phase II detoxification reactions [3]. The intuitive leap, that more glutathione must mean more liver protection, is not something any trial in this specific combination has tested.

What People Are Actually Asking

Searches for "glutathione with Accutane" generally split into two groups. One takes oral glutathione capsules (250 to 1,000 mg/day) for skin or general wellness and wants to know whether to pause it during isotretinoin. The other is considering IV glutathione pushes at med spas, often marketed for "detox" or "glow." These carry meaningfully different risk profiles, covered separately below.

Pharmacokinetic Interaction: What the Evidence Shows

No published pharmacokinetic study has measured how glutathione co-administration affects isotretinoin plasma levels, AUC, or Cmax. That is an absence of data, not evidence of safety, so the assessment below is built from mechanism rather than a direct trial.

Enzyme-Mediated Interaction

Isotretinoin's metabolism involves cytochrome P450 pathways [16]. Glutathione does not appear as an inhibitor or inducer on standard CYP interaction references, including the Flockhart Cytochrome P450 Drug Interaction Table [4], and the Natural Medicines database used by pharmacists lists no CYP-mediated interaction between glutathione and isotretinoin [5]. This is reassuring for a specific, narrow question, whether glutathione changes isotretinoin blood levels through enzyme inhibition, but it does not address the pharmacodynamic (liver-burden) question discussed below.

Oral Bioavailability Is Low

An older pharmacokinetic study found that orally administered glutathione is largely hydrolyzed by intestinal gamma-glutamyltransferase before absorption, with only a small fraction reaching systemic circulation intact [7]. A more recent randomized, placebo-controlled trial found that sustained oral glutathione supplementation (250 or 1,000 mg/day for 6 months) did raise measured blood glutathione markers compared to placebo [6], which shows the supplement does something systemically, but the two findings together suggest the added exposure from standard oral doses is modest relative to the body's own hepatic glutathione pool.

Protein Binding

Isotretinoin's protein binding is very high (around 99.9%, mostly to albumin) [16]. Glutathione circulates largely as a free tripeptide or in its oxidized form within red blood cells rather than competing for albumin binding sites, so a displacement interaction is not expected on mechanistic grounds. No study has tested this directly.

Pharmacodynamic Interaction: The More Relevant Question

The practical issue is less about drug metabolism and more about what happens at the organ level when a drug that can stress the liver is combined with a supplement whose whole job is neutralizing that kind of stress.

Shared Hepatic Burden

Isotretinoin-related liver enzyme changes are thought by some researchers to involve oxidative stress within hepatocytes, though this mechanism is not fully established. Glutathione's core role is buffering exactly that kind of stress, and glutathione depletion has been described as a common feature across multiple types of drug-induced liver injury [9]. That is a mechanistic argument that glutathione supplementation could theoretically be protective, but no trial has tested whether it actually reduces isotretinoin-associated transaminase elevations. This is a genuine evidence gap, not a settled point in either direction.

Could Antioxidants Blunt Isotretinoin's Effect on Acne?

This is a common theoretical worry: if isotretinoin's benefit partly depends on oxidative effects in the sebaceous gland, would an antioxidant blunt it? Isotretinoin's primary acne-clearing mechanism operates through retinoid receptor (RAR/RXR) signaling and changes in sebocyte differentiation, pathways that are not primarily redox-dependent [10]. That makes reduced efficacy from glutathione mechanistically unlikely, but "unlikely on mechanistic grounds" is not the same as "tested and ruled out."

Evidence-Status Interaction Assessment

Oral Glutathione: Practical Risk Assessment

For standard oral glutathione capsules (250 to 1,000 mg/day), the practical risk during isotretinoin appears low based on available mechanistic evidence, though it has not been directly studied.

What Supports This Assessment

Three points converge: oral glutathione has low systemic bioavailability, limiting how much reaches the liver from a standard dose [7]; no CYP450 inhibition or induction has been documented for glutathione [4]; and hepatocytes already contain glutathione at millimolar concentrations, so an oral supplement's incremental contribution is proportionally small [3].

What to Watch For

Do not skip or space out your scheduled liver function tests because you are taking glutathione. If transaminase values rise above the threshold your prescriber uses to hold isotretinoin, that decision should be made the same way regardless of supplement use.

Nausea and abdominal discomfort can occur with both isotretinoin and oral glutathione. Separating doses by roughly 2 hours may reduce additive GI irritation, though this is a comfort measure rather than a documented pharmacokinetic necessity.

IV Glutathione: A Different Risk Profile

Injectable glutathione, given as an IV push at med spas or wellness clinics, introduces concerns that oral supplements do not raise.

Compounding and Quality Variability

IV glutathione is not an FDA-approved injectable product. It is prepared by compounding pharmacies under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act, and compounded sterile products are subject to FDA quality oversight that has, at various facilities over the years, turned up sterility and quality problems [12]. Contaminated or poorly compounded injectables could plausibly cause liver inflammation that would look identical to isotretinoin-related liver stress on routine labs; this is a quality-control risk inherent to compounded injectables generally, not a documented event specific to glutathione and isotretinoin together.

Dose and Timing Concerns

An IV glutathione session delivers a much larger dose directly into the bloodstream than an oral capsule ever could, bypassing the gut hydrolysis that limits oral absorption. Whether this bolus affects isotretinoin clearance or liver handling has never been studied.

Why Combining Them Complicates Monitoring

The clearest, most defensible concern is not toxicity but ambiguity: if a patient on isotretinoin receives IV glutathione and their next liver panel shows elevated enzymes, there is no reliable way to determine from the lab result alone whether isotretinoin, the IV glutathione, the compounded product's quality, or some other factor caused it. That ambiguity can lead a prescriber to pause or stop isotretinoin out of caution even if the drug was not the cause, which extends the treatment course and delays acne clearance. This is a practical, evidence-supportable reason to avoid combining IV glutathione with an active isotretinoin course and its lab monitoring window, independent of whether either substance is individually risky.

NAC as a Glutathione Precursor: An Alternative Consideration

N-acetylcysteine (NAC), a direct precursor to intracellular glutathione synthesis, is sometimes considered instead of glutathione supplements during isotretinoin therapy.

What the Data Shows

NAC has an established hepatoprotective role; it is the FDA-approved antidote for acetaminophen-induced liver injury, where it works by replenishing hepatic glutathione stores [13]. A small pilot study is said to have examined NAC alongside isotretinoin and found no significant difference in transaminase elevations between the NAC and placebo groups, but the study was underpowered to detect anything but a large effect, so this should be read as "no signal found" rather than "proven equivalent to placebo."

NAC and CYP Interactions

Like glutathione, NAC does not inhibit or induce CYP2C8, CYP3A4, or CYP2C9 at therapeutic doses [13]. Its interaction profile with isotretinoin mirrors glutathione's: no documented pharmacokinetic interaction, with a plausible but clinically unproven pharmacodynamic benefit.

Monitoring During Isotretinoin, With or Without Glutathione

If you and your prescriber decide to continue glutathione during isotretinoin, the monitoring plan itself does not change, but staying consistent with it matters more.

Baseline and Ongoing Labs

Follow your prescriber's standard isotretinoin monitoring protocol, which typically includes a baseline liver panel with repeat testing at intervals through the course [11][16]. Specific intervals and thresholds vary by prescriber and by patient risk factors, so confirm your own schedule rather than assuming a fixed cadence.

Reasons to Stop Glutathione and Call Your Prescriber

• Liver enzymes rising above the threshold your prescriber has set for you
• New jaundice, dark urine, or right upper quadrant pain
• Persistent nausea or vomiting that starts after adding the supplement

Tell Your Prescriber, Even If It Feels Unrelated

Mention any glutathione or NAC use, oral or IV, before starting isotretinoin and if you start it mid-course. Supplement use is not always captured in standard treatment documentation, so noting it directly with your dermatologist helps them interpret any lab changes accurately.

Dose-Separation Strategy

No pharmacokinetic data requires spacing isotretinoin and glutathione apart, but a roughly 2-hour gap is a reasonable precaution for two practical reasons. Isotretinoin's absorption is known to increase with a high-fat meal [16], so taking glutathione at a different time than your fattiest meal avoids any theoretical competition for absorption at that meal. Spacing the two also makes it easier to tell which one might be responsible if GI symptoms appear.

A practical approach: take isotretinoin with your day's highest-fat meal (often dinner), and take glutathione earlier in the day.

What the Guidelines Say

Isotretinoin management guidance from the American Academy of Dermatology addresses monitoring and known contraindications but does not specifically address glutathione supplementation [11]. Vitamin A supplements are the one clearly flagged concurrent supplement to avoid, due to additive hypervitaminosis A risk when combined with a vitamin A derivative like isotretinoin [11][16].

The absence of guideline language on glutathione reflects a lack of dedicated clinical trial data on this combination, not an implicit endorsement of safety. The FDA's Adverse Event Reporting System (FAERS) is a passive, voluntary reporting database, and supplement-drug combinations like this one are not systematically coded within it, so an absence of flagged reports there does not confirm the combination is safe, only that no formal safety signal has surfaced through that channel [15].

If you are taking isotretinoin and want to continue oral glutathione, the reasonable approach based on available evidence is: confirm the plan with your prescriber, keep your full LFT monitoring schedule, and hold off on IV glutathione until your isotretinoin course and monitoring window are finished.